Overview

The Efficacy and Safety of Magnesium Sulphate Adjuvant in Scalp Block With Ropivacaine for Supratentorial Craniotomy: a Prospective, Randomized Controlled Trial

Status:
COMPLETED

Trial end date:
2025-05-20

Target enrollment:

Participant gender:

Summary

A randomized, double-blinded controlled trial was conducted to evaluate the analgesic efficacy of MgSO4 as an adjuvant to ropivacaine in scalp blocks for craniotomy, focusing on its impact on hemodynamic parameters and intraoperative remifentanil consumption.

Phase:

PHASE4

Details

Lead Sponsor:

Hospital Universiti Sains Malaysia

Treatments:

Ropivacaine